Silver Book Fact

A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.

Bradley C, Yabroff K, Dahman B, Feuer E, et al. Productivity Costs of Cancer Mortality in the United States: 2000-2020. J Natl Cancer Inst. 2008; 100(24): 1763-70. http://www.ncbi.nlm.nih.gov/pubmed/19066273

Reference

Title
Productivity Costs of Cancer Mortality in the United States: 2000-2020
Publication
J Natl Cancer Inst
Publication Date
2008
Authors
Bradley C, Yabroff K, Dahman B, Feuer E, et al.
Volume & Issue
Volume 100, Issue 24
Pages
1763-70
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Between August 2004 and July 2014, the FDA approved: Six new anticancer therapeutics Five new uses for previously approved anticancer therapeutics Two new uses for imaging agents One new use for a screening test  
  • Following the current path, the prostate cancer incidence rate will increase by 75.4% (786,000) between 2003 and 2023. If an alternative path is taken, there will be 21.5% (393,000) fewer…  
  • Cancer death rates for all races/ethnicities and both sexes combined decreased by 2.1% per year from 2002-2004, nearly twice the annual decrease of 1.1% per year from 1993-2002.  
  • Cervical cancer screening reduces incidence by over 80%.  
  • Without screening and adjuvant therapy, the death rate for breast cancer would have increased by about 30 percent between 1975 and 2000.